Nabil F Saba, MD,
FACP, is Professor and Vice Chair for Quality and Safety in the Department of
Hematology and Medical Oncology and holds a joint appointment as Professor in
the Department of Otolaryngology at Emory University School of Medicine. Dr.
Saba is The Lynne and Howard Halpern Chair in Head and Neck Cancer Research,
and serves as Co-Director of the Head and Neck Cancer Multidisciplinary Program
at Winship Cancer Institute of Emory University. He is the elected Chair of the
National Cancer Institute's task force for recurrent metastatic head and neck
cancer, and chaired the Rare Tumors Task Force of the National Cancer
Institute's Head and Neck Cancer Steering Committee. He is also a member of the
NRG Oncology and Eastern Cooperative Oncology Group (ECOG) Head and Neck Cancer
Core Committees. He has been appointed as a member of the ASCO clinical
guidelines committee as well as the ASCO Head and Neck Guideline Advisory
Group. He earned his Medical Degree from the American University of Beirut Medical
School. He completed a Residency in Internal Medicine at Tufts University
School of Medicine in Boston, and a Clinical Fellowship in Hematology and
Oncology at Brown University School of Medicine, and a Bone Marrow Transplant
Fellowship at the University of Toronto Princess Margaret Hospital in Toronto,
Canada.
Nabil F Saba, MD,
FACP, is Professor and Vice Chair for Quality and Safety in the Department of
Hematology and Medical Oncology and holds a joint appointment as Professor in
the Department of Otolaryngology at Emory University School of Medicine. Dr.
Saba is The Lynne and Howard Halpern Chair in Head and Neck Cancer Research,
and serves as Co-Director of the Head and Neck Cancer Multidisciplinary Program
at Winship Cancer Institute of Emory University. He is the elected Chair of the
National Cancer Institute's task force for recurrent metastatic head and neck
cancer, and chaired the Rare Tumors Task Force of the National Cancer
Institute's Head and Neck Cancer Steering Committee. He is also a member of the
NRG Oncology and Eastern Cooperative Oncology Group (ECOG) Head and Neck Cancer
Core Committees. He has been appointed as a member of the ASCO clinical
guidelines committee as well as the ASCO Head and Neck Guideline Advisory
Group. He earned his Medical Degree from the American University of Beirut Medical
School. He completed a Residency in Internal Medicine at Tufts University
School of Medicine in Boston, and a Clinical Fellowship in Hematology and
Oncology at Brown University School of Medicine, and a Bone Marrow Transplant
Fellowship at the University of Toronto Princess Margaret Hospital in Toronto,
Canada.